Erlotinib 25 mg, 100 mg, 150 mg Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 25 mg, 100 mg, 150 mg
Reference Brands: Tarceva (US & EU), Erlocip (India)
Category: Oncology Cancer Care
Erlotinib is a targeted oral therapy for NSCLC and pancreatic cancer, available as 25 mg, 100 mg, and 150 mg tablets in the US and EU under Tarceva® and generics.
Product Description:
Erlotinib Tablets are a targeted oncology treatment used in the EU and US, primarily indicated for non-small cell lung cancer (NSCLC) with EGFR mutations and advanced pancreatic cancer. As a tyrosine kinase inhibitor (TKI), Erlotinib works by inhibiting the epidermal growth factor receptor (EGFR), slowing cancer cell proliferation. Available in 25 mg, 100 mg, and 150 mg strengths, Erlotinib is marketed under the brand name Tarceva® and widely distributed as a generic formulation across global markets. Pharmaceutical distributors and B2B buyers rely on Erlotinib as a high-value, targeted therapy with well-established clinical efficacy in precision oncology.
Erlotinib — third party manufacturing & bulk supply
Erlotinib 25 mg, 100 mg, 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Erlotinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Erlotinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Erlotinib is used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. It is often prescribed for patients whose tumors have specific epidermal growth factor receptor (EGFR) mutations.
Erlotinib Hydrochloride is a synthetic small-molecule inhibitor that targets the epidermal growth factor receptor (EGFR) tyrosine kinase. By blocking EGFR signaling, it helps slow or stop the growth of cancer cells.
The most well-known trade name is Tarceva.
The original brand Tarceva was developed and marketed by Roche and Astellas Pharma. Many pharmaceutical companies now manufacture generic versions worldwide.
The generic name is Erlotinib Hydrochloride.
Brand names include Tarceva, Erlocip, Erlonat, and several generic versions marketed globally.
Erlotinib products are manufactured in several countries including the United States, Switzerland, India, and various EU pharmaceutical manufacturing hubs depending on the manufacturer.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
